The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Protein tyrosine kinase 6 (PTK6, BRK) amplification in HER2+ breast cancer as a mechanism of HER2 resistance.
Tatyana A. Grushko
No relevant relationships to disclose
Maria J. Gomez-Vega
No relevant relationships to disclose
Aleix Prat
No relevant relationships to disclose
Jeffrey Mueller
No relevant relationships to disclose
Mariann Coyle
No relevant relationships to disclose
Charles M. Perou
No relevant relationships to disclose
Rodrigo Santa Cruz Guindalini
No relevant relationships to disclose
Elias Obeid
No relevant relationships to disclose
Hanna Irie
No relevant relationships to disclose
Olufunmilayo I. Olopade
No relevant relationships to disclose